Biochemical Reagent
-
BA9024 SovleplenibSummary: Sovalleplenib (HMPL-523) is a potent, orally available selective inhibitor. - BA9025 CevidoplenibSummary: Cevidoplenib (SKI-O-703) is an orally active spleen tyrosine kinase inhibitor with potential anti-inflammatory and immunomodulatory effects.
- BA9026 R112Summary: R112 is a rapid and reversible kinase inhibitor of spleen tyrosine kinase.
- BA9027 Syk-IN-1Summary: Syk-IN-1 is a potent inhibitor.
- BA9028 Syk-IN-4Summary: Syk-IN-4 is a potent, selective inhibitor with oral activity.
- BA9029 ER-27319Summary: ER-27319 is an acridone derivative.
- BA9030 UNC2541Summary: UNC2541 is a potent Mer tyrosine kinase-specific inhibitor.
- BA9031 UNC569Summary: UNC569 is a potent, reversible, ATP-competitive and orally active kinase inhibitor.
- BA9032 RU-301Summary: RU-301 is a pan-type inhibitor that blocks induced activation and tumorigenicity.
- BA9033 UNC1062Summary: UNC1062 is a selective tyrosine kinase inhibitor that reduces MERTK-mediated activation of downstream signaling, induces apoptosis in culture, reduces colony formation in soft agar, and inhibits melanoma cell invasion.